doi: 10.1016/s0015-0282(16)60121-8.
Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression
Affiliations
- PMID: 3137095
- DOI: 10.1016/s0015-0282(16)60121-8
Item in Clipboard
Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression
Fertil Steril.
1988 Sep.
Free article
Abstract
The time course of suppression of ovarian estrogen production and follicular development with leuprolide was examined in 40 normal women before ovarian stimulation for in vitro fertilization (IVF). Initiation of leuprolide during the midluteal phase caused a significantly more prompt suppression than when treatment was started during the early follicular phase (day 1). Injection of the same total amount of leuprolide in two divided doses also caused a significantly more prompt suppression. These two methods were consistent enough to make routine use of leuprolide practical before ovarian stimulation for IVF.
Similar articles
-
Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success.Fertil Steril. 1991 Sep;56(3):500-4. doi: 10.1016/s0015-0282(16)54548-8. Fertil Steril. 1991. PMID: 1909977
-
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.Fertil Steril. 1989 Feb;51(2):292-7. doi: 10.1016/s0015-0282(16)60493-4. Fertil Steril. 1989. PMID: 2492234 Clinical Trial.
-
Ovarian suppression with leuprolide acetate: comparison of luteal, follicular, and flare-up administration in controlled ovarian hyperstimulation for oocyte retrieval.J In Vitro Fert Embryo Transf. 1990 Apr;7(2):94-7. doi: 10.1007/BF01135581. J In Vitro Fert Embryo Transf. 1990. PMID: 2113562
-
Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.Fertil Steril. 1991 Jan;55(1):119-24. doi: 10.1016/s0015-0282(16)54070-9. Fertil Steril. 1991. PMID: 1898886
-
Role of gonadotropin releasing hormone agonists in ovulation induction.J Reprod Med. 1989 Jan;34(1 Suppl):76-80. J Reprod Med. 1989. PMID: 2497247 Review.
Cited by
-
Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.J In Vitro Fert Embryo Transf. 1989 Dec;6(6):345-52. doi: 10.1007/BF01138775. J In Vitro Fert Embryo Transf. 1989. PMID: 2517507
-
Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles.J Assist Reprod Genet. 1995 May;12(5):301-4. doi: 10.1007/BF02213708. J Assist Reprod Genet. 1995. PMID: 8520192
-
Oxidative Stress Markers in GnRH Agonist and Antagonist Protocols in IVF.J Med Biochem. 2017 Apr 22;36(2):163-170. doi: 10.1515/jomb-2017-0001. eCollection 2017 Apr. J Med Biochem. 2017. PMID: 28680360 Free PMC article.
-
Serum inhibin B correlates with successful ovulation in infertile women.J Assist Reprod Genet. 2003 Jun;20(6):241-7. doi: 10.1023/a:1024111629191. J Assist Reprod Genet. 2003. PMID: 12877256 Free PMC article.
-
A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.Sleep. 2013 Dec 1;36(12):1977-85. doi: 10.5665/sleep.3244. Sleep. 2013. PMID: 24293774 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
